Restylane - Youthful Aesthetics LLC

Natural Elegance

We offer a variety of Restylane® fillers including Restylane®-L, Restylane® Lyft, Restylane® Contour, Restylane® Refyne, Restylane® Silk and Restylane® Kysse. Restylane® L, Lyft, Contour, and Refyne can be used in combination for correction of volume loss and moderate to severe facial wrinkles and folds in the following areas: nasolabial folds, cheeks, tear troughs, marionette lines, and others. Restylane® Silk and Kysse can be used in the lip and surrounding mouth areas for volume loss and enhancement.

Important Product Information

Here are some answers to the questions we receive the most about our services. If we missed anything, please do not hesitate to contact us. We’ll be happy to help.

What Are The Contraindications?

Do not take Restylane® if you…

Are allergic to lidocaine or any of the gram-positive bacterial proteins used to make hyaluronic acid.
Are prone to bleeding or have been diagnosed with a bleeding disorder.
Have had severe allergies with a history of severe reactions (anaphylaxis).

Does The Procedure Hurt?

We strive to make your experience as comfortable as possible. We use various techniques which help minimize the client’s discomfort.

What Are Possible Side Effects?

The most commonly observed side effects are swelling, redness, pain, bruising, and tenderness at the injection site. With all skin injection procedures, there is a risk of infection.

How Long Is It Indicated?

Restylane® L is FDA indicated for treatment improvements lasting 6-9 months with one treatment. When retreated at month 4 OR month 9, the FDA indication for treatment improvement extends to 18 months.

Restylane® Refyne, Contour, and Kysse all have FDA indications for treatment improvements lasting up-to 1 year.

Restylane® Lyft is FDA indicated for treatment of cheek volume improvements lasting up-to 1 year.

Restylane® Silk is FDA indicated for treatment improvements lasting 6-9 months.

For more information about this product please visit Restylane’s® website.